publication venue for
- Influence of patient age and comorbid burden on clinician attitudes toward heart failure guidelines.. 10:211-8. 2012
- Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.. 9:434-41. 2011
- Antipsychotic use and the risk of diabetes in nursing home residents with dementia.. 9:153-63. 2011
- Primary care providers' perspectives on psychoactive medication disorders in older adults.. 9:164-72. 2011
- Medication Use and Functional Status Decline in Older Adults: A Narrative Review. 9:378-391. 2011
- Year in Review: Medication Mishaps in the Elderly. 9:1-10. 2011
- Inpatient medication reconciliation at admission and discharge: A retrospective cohort study of age and other risk factors for medication discrepancies.. 8:115-26. 2010
- A review of the effect of anticonvulsant medications on bone mineral density and fracture risk.. 8:34-46. 2010
- Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition.. 8:4-33. 2010
- A taxonomy of reasons for not prescribing guideline-recommended medications for patients with heart failure.. 8:583-94. 2010
- Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.. 7:74-83. 2009
- Addressing delays in medication administration for patients transferred from the hospital to the nursing home: a pilot quality improvement project.. 6:205-11. 2008
- Contraindicated medication use among patients in a memory disorders clinic.. 6:147-52. 2008
- Appropriate proton pump inhibitor use among older adults: a retrospective chart review.. 6:249-54. 2008
- Distribution and correlates of serum 25-hydroxyvitamin D levels in a sample of patients with hip fracture.. 5:335-40. 2007
- Risks of combined alcohol/medication use in older adults.. 5:64-74. 2007
- Polypharmacy and the balance of medication benefits and risks.. 5:314-6. 2007
- Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.. 4:42-51. 2006